indoleacetic acid has been researched along with Inflammation in 8 studies
indoleacetic acid: RN given refers to unlabeled parent cpd; structure in Merck Index, 9th ed, #4841
auxin : Any of a group of compounds, both naturally occurring and synthetic, that induce cell elongation in plant stems (from Greek alphaupsilonxialphanuomega, "to grow").
indole-3-acetic acid : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1H-indol-3-yl group.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adults with chronic kidney disease (CKD) exhibit alterations in tryptophan metabolism, mainly via the kynurenine pathway, due to higher enzymatic activity induced mainly by inflammation." | 7.83 | Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study. ( Davies, N; Hilder, EF; Jose, MD; Karu, N; McKercher, C; Nichols, DS; Shellie, RA, 2016) |
| "Adults with chronic kidney disease (CKD) exhibit alterations in tryptophan metabolism, mainly via the kynurenine pathway, due to higher enzymatic activity induced mainly by inflammation." | 3.83 | Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study. ( Davies, N; Hilder, EF; Jose, MD; Karu, N; McKercher, C; Nichols, DS; Shellie, RA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Ji, Y | 1 |
| Gao, Y | 1 |
| Chen, H | 1 |
| Yin, Y | 1 |
| Zhang, W | 1 |
| Olivier, V | 1 |
| Dunyach-Remy, C | 1 |
| Corbeau, P | 1 |
| Cristol, JP | 1 |
| Sutra, T | 1 |
| Burtey, S | 1 |
| Lavigne, JP | 1 |
| Moranne, O | 1 |
| Chowdhury, MMI | 1 |
| Kurata, K | 1 |
| Yuasa, K | 1 |
| Koto, Y | 1 |
| Nishimura, K | 1 |
| Shimizu, H | 1 |
| Krishnan, S | 1 |
| Ding, Y | 1 |
| Saedi, N | 1 |
| Choi, M | 1 |
| Sridharan, GV | 1 |
| Sherr, DH | 1 |
| Yarmush, ML | 1 |
| Alaniz, RC | 1 |
| Jayaraman, A | 1 |
| Lee, K | 1 |
| Kim, DC | 1 |
| Quang, TH | 1 |
| Yoon, CS | 1 |
| Ngan, NTT | 1 |
| Lim, SI | 1 |
| Lee, SY | 1 |
| Kim, YC | 1 |
| Oh, H | 1 |
| Segal, LN | 1 |
| Clemente, JC | 1 |
| Wu, BG | 1 |
| Wikoff, WR | 1 |
| Gao, Z | 1 |
| Li, Y | 1 |
| Ko, JP | 1 |
| Rom, WN | 1 |
| Blaser, MJ | 1 |
| Weiden, MD | 1 |
| Karu, N | 1 |
| McKercher, C | 1 |
| Nichols, DS | 1 |
| Davies, N | 1 |
| Shellie, RA | 1 |
| Hilder, EF | 1 |
| Jose, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study[NCT02557958] | Early Phase 1 | 19 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for indoleacetic acid and Inflammation
| Article | Year |
|---|---|
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Chemokine CXCL1; Cytokines; | 2017 |
7 other studies available for indoleacetic acid and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress.
Topics: Animals; Indoleacetic Acids; Inflammation; Lipids; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57B | 2019 |
Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study.
Topics: Bacterial Translocation; Biomarkers; C-Reactive Protein; Female; Gastrointestinal Microbiome; Humans | 2020 |
Suppression of TNFα expression induced by indole-3-acetic acid is not mediated by AhR activation in Caco-2 cells.
Topics: Caco-2 Cells; Humans; Indoleacetic Acids; Inflammation; Receptors, Aryl Hydrocarbon; Tumor Necrosis | 2021 |
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages.
Topics: Animals; Cytokines; Dietary Fats; Fatty Acid Synthase, Type I; Gastrointestinal Microbiome; Hep G2 C | 2018 |
Anti-neuroinflammatory activities of indole alkaloids from kanjang (Korean fermented soy source) in lipopolysaccharide-induced BV2 microglial cells.
Topics: Animals; Anti-Inflammatory Agents; Carbolines; Cell Nucleus; Cell Survival; Cyclooxygenase 2; Cytoso | 2016 |
Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.
Topics: Aged; Aged, 80 and over; Anxiety; Biomarkers; Cognition; Cross-Sectional Studies; Depression; Female | 2016 |